Kazuo Inoue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kazuo Inoue has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Tsuyoshi Goto
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Uji, Kyoto 611-0011, Japan
5 shared publications - Haruya Takahashi
Graduate School of Agriculture, Kyoto University , Kyoto
4 shared publications Jungin Kwon
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University , Uji, Kyoto
4 shared publications- Masatoshi Matsumoto
Department of Community-Based Medical System, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
4 shared publications Satoko Kawarasaki
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University , Uji, Kyoto
4 shared publications- Shigenobu Matsumura
Department of Nutrition Osaka Metropolitan University Osaka Japan
4 shared publications
Latest Publications
- Open Access
- 9 November 2024
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 89 (2) , 193-200
Lipid metabolism and food ingredients from the perspective of thermogenic adipocytes
The high heat-producing capacity of brown and beige adipocytes, collectively known as thermogenic adipocytes, contributes to whole-body energy expenditure and is an attractive target for the management of obesity. It has been revealed that the functions of thermogenic adipocytes are important for the regulation of whole-body carbohydrate and lipid metabolism, and the activation of thermogenic adipocytes seems to have beneficial effects for the management of obesity-related metabolic disorders, such as dyslipidemia. Recent studies have showed that specific food ingredients have the potential to activate thermogenic adipocytes via various mechanisms. Some of these are effective not only in rodents, but also in humans, and effective prevention of obesity using these food ingredients is expected. In this review, we introduce the recent findings on the regulatory mechanisms of lipid metabolism by thermogenic adipocytes and food ingredients, demonstrating the potential to activate thermogenic adipocytes and their underlying mechanisms.
- 9 November 2024
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 89 (2) , 193-200
Open AccessLipid metabolism and food ingredients from the perspective of thermogenic adipocytes
The high heat-producing capacity of brown and beige adipocytes, collectively known as thermogenic adipocytes, contributes to whole-body energy expenditure and is an attractive target for the management of obesity. It has been revealed that the functions of thermogenic adipocytes are important for the regulation of whole-body carbohydrate and lipid metabolism, and the activation of thermogenic adipocytes seems to have beneficial effects for the management of obesity-related metabolic disorders, such as dyslipidemia. Recent studies have showed that specific food ingredients have the potential to activate thermogenic adipocytes via various mechanisms. Some of these are effective not only in rodents, but also in humans, and effective prevention of obesity using these food ingredients is expected. In this review, we introduce the recent findings on the regulatory mechanisms of lipid metabolism by thermogenic adipocytes and food ingredients, demonstrating the potential to activate thermogenic adipocytes and their underlying mechanisms.
- 6 April 2023
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 87 (7) , 747-757
8-Prenyl daidzein and 8-prenyl genistein from germinated soybean modulate inflammatory response in activated macrophages
Soy isoflavones have been shown to have anti-inflammatory properties; however, the anti-inflammatory effects of isoflavone metabolites produced during soybean germination remain unclear. We found that the daidzein and genistein derivatives, 8-prenyl daidzein (8-PD) and 8-prenyl genistein (8-PG), demonstrated a more potent effect than daidzein and genistein on repressing inflammatory responses in macrophages. Although IkB protein levels were unaltered, 8-PD and 8-PG repressed nuclear factor kappa B (NF-κB) activation, which was associated with reduced ERK1/2, JNK, and p38 MAPK activation and suppressed mitogen- and stress-activated kinase 1 phosphorylation. Inflammatory responses induced by the medium containing hypertrophic adipocyte secretions were successfully suppressed by 8-PD and 8-PG treatment. In the ex vivo study, 8-PD and 8-PG significantly inhibited proinflammatory C–C motif chemokine ligand 2 (CCL2) secretion from the adipose tissues of mice fed a long-term high-fat diet. The data suggest that 8-PD and 8-PG could regulate macrophage activation under obesity conditions.
- 6 April 2023
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 87 (7) , 747-757
8-Prenyl daidzein and 8-prenyl genistein from germinated soybean modulate inflammatory response in activated macrophages
Soy isoflavones have been shown to have anti-inflammatory properties; however, the anti-inflammatory effects of isoflavone metabolites produced during soybean germination remain unclear. We found that the daidzein and genistein derivatives, 8-prenyl daidzein (8-PD) and 8-prenyl genistein (8-PG), demonstrated a more potent effect than daidzein and genistein on repressing inflammatory responses in macrophages. Although IkB protein levels were unaltered, 8-PD and 8-PG repressed nuclear factor kappa B (NF-κB) activation, which was associated with reduced ERK1/2, JNK, and p38 MAPK activation and suppressed mitogen- and stress-activated kinase 1 phosphorylation. Inflammatory responses induced by the medium containing hypertrophic adipocyte secretions were successfully suppressed by 8-PD and 8-PG treatment. In the ex vivo study, 8-PD and 8-PG significantly inhibited proinflammatory C–C motif chemokine ligand 2 (CCL2) secretion from the adipose tissues of mice fed a long-term high-fat diet. The data suggest that 8-PD and 8-PG could regulate macrophage activation under obesity conditions.
- 1 May 2022
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 322 (5) , E436-E445
Stimulation of Gs signaling in MC4R cells by DREADD increases energy expenditure, suppresses food intake, and increases locomotor activity in mice
We report that Gs signaling in melanocortin 4 receptor (MC4R)-expressing cells regulates energy expenditure, appetite, and locomotor activity. These findings shed light on the mechanism underlying the regulation of energy metabolism and locomotor activity by MC4R/cAMP signaling.
- 1 May 2022
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 322 (5) , E436-E445
Stimulation of Gs signaling in MC4R cells by DREADD increases energy expenditure, suppresses food intake, and increases locomotor activity in mice
We report that Gs signaling in melanocortin 4 receptor (MC4R)-expressing cells regulates energy expenditure, appetite, and locomotor activity. These findings shed light on the mechanism underlying the regulation of energy metabolism and locomotor activity by MC4R/cAMP signaling.
- 31 January 2022
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 86 (4) , 509-518
Application of a novel fluorescence intensity assay: identification of distinct fatty acetates as volatile compounds that bind specifically to amino acid region 149-168 of a transmembrane receptor CD36
The cluster of differentiation 36 (CD36) is a transmembrane receptor expressed in various cells and has diverse lipid ligands. The expression of CD36 in the murine olfactory epithelium and its ability to recognize certain species of fatty aldehydes, a class of odor-active volatile compounds, have suggested a role for this receptor in the capture of specific odorants in the nasal cavity of mammals. However, the spectrum of CD36-recognizable volatile compounds is poorly understood. In this study, we employed our recently devised assay with fluorescently labeled peptides as probes (fluorescence intensity assay) and identified distinct fatty acetates as volatile compounds that bind specifically to amino acid region 149-168 of CD36 (eg dodecyl and tetradecyl acetates). The present findings demonstrate the utility of our assay for the discovery of novel CD36 ligands and support the notion that the receptor functions as a captor of volatile compounds in the mammalian olfactory system.
- 31 January 2022
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 86 (4) , 509-518
Application of a novel fluorescence intensity assay: identification of distinct fatty acetates as volatile compounds that bind specifically to amino acid region 149-168 of a transmembrane receptor CD36
The cluster of differentiation 36 (CD36) is a transmembrane receptor expressed in various cells and has diverse lipid ligands. The expression of CD36 in the murine olfactory epithelium and its ability to recognize certain species of fatty aldehydes, a class of odor-active volatile compounds, have suggested a role for this receptor in the capture of specific odorants in the nasal cavity of mammals. However, the spectrum of CD36-recognizable volatile compounds is poorly understood. In this study, we employed our recently devised assay with fluorescently labeled peptides as probes (fluorescence intensity assay) and identified distinct fatty acetates as volatile compounds that bind specifically to amino acid region 149-168 of CD36 (eg dodecyl and tetradecyl acetates). The present findings demonstrate the utility of our assay for the discovery of novel CD36 ligands and support the notion that the receptor functions as a captor of volatile compounds in the mammalian olfactory system.
- 22 December 2021
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 86 (3) , 380-389
Screening of flavor compounds usingUcp1-luciferase reporter beige adipocytes identified 5-methylquinoxaline as a novel UCP1-inducing compound
Uncoupling protein 1 (UCP1) in brown or beige adipocytes is a mitochondrial protein that is expected to enhance whole-body energy expenditure. For the high-throughput screening of UCP1 transcriptional activity regulator, we established a murine inguinal white adipose tissue-derived Ucp1-luciferase reporter preadipocyte line. Using this reporter preadipocyte line, 654 flavor compounds were screened, and a novel Ucp1 expression-inducing compound, 5-methylquinoxaline, was identified. Adipocytes treated with 5-methylquinoxaline showed increased Ucp1 mRNA expression levels and enhanced oxygen consumption. 5-Methylquinoxaline induced Ucp1 expression through peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α), and 5-methylquinoxaline-induced PGC1α activation seemed to be partially regulated by its phosphorylation or deacetylation. Thus, our Ucp1-luciferase reporter preadipocyte line is a useful tool for screening of Ucp1 inductive compounds.
- 22 December 2021
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 86 (3) , 380-389
Screening of flavor compounds usingUcp1-luciferase reporter beige adipocytes identified 5-methylquinoxaline as a novel UCP1-inducing compound
Uncoupling protein 1 (UCP1) in brown or beige adipocytes is a mitochondrial protein that is expected to enhance whole-body energy expenditure. For the high-throughput screening of UCP1 transcriptional activity regulator, we established a murine inguinal white adipose tissue-derived Ucp1-luciferase reporter preadipocyte line. Using this reporter preadipocyte line, 654 flavor compounds were screened, and a novel Ucp1 expression-inducing compound, 5-methylquinoxaline, was identified. Adipocytes treated with 5-methylquinoxaline showed increased Ucp1 mRNA expression levels and enhanced oxygen consumption. 5-Methylquinoxaline induced Ucp1 expression through peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α), and 5-methylquinoxaline-induced PGC1α activation seemed to be partially regulated by its phosphorylation or deacetylation. Thus, our Ucp1-luciferase reporter preadipocyte line is a useful tool for screening of Ucp1 inductive compounds.
- Open Access
- 1 December 2021
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 17 (11) , e925-e931
Linear concentration-response relationship of serum caffeine with adenosine-induced fractional flow reserve overestimation: a comparison with papaverine
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 December 2021
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 17 (11) , e925-e931
Open AccessLinear concentration-response relationship of serum caffeine with adenosine-induced fractional flow reserve overestimation: a comparison with papaverine
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- Open Access
- 20 March 2021
- Published by The Japan Primary Care Association in An Official Journal of the Japan Primary Care Association
- Vol. 44 (1) , 23-29
The significance of conducting research in primary care, and the two matters essential to produce successful outcomes
筆者はへき地で医師としてのキャリアを始めた.その経験から,日々の臨床現場で湧き上がる疑問や仮説について取り組むPractice based researchを実践し,提唱している.今回,本学会編集委員会より投稿依頼をいただいた.熟慮した結果,プライマリ・ケアで研究をする意義,そしてその研究成果を出すために必要なことについて書くことにした.常日頃から,プライマリ・ケアでの研究について興味を持つ若手は多いものの,なかなか前に進めず経験を積めないということを感じていた.実際にそのような悩みを相談されたこともある.そこでまず,現場での研究をしていくことが楽しくかつ最も良い自己研鑽につながってきたという経験を述べた.次に,そのために大切だと思っている二つのことについて実際の経験を基に書き連ねた.その一つは,キャリアの早期から研究に取り組む意義であり,若手の方々に伝えたいことである.もう一つは,より重要であるが次世代が良い環境で研究を実践するには指導者はどうすれば良いのかである.若手を指導する立場にある,あるいは将来なるであろう中堅の方々に考えていただく,その一助になればと考えている.
- 20 March 2021
- Published by The Japan Primary Care Association in An Official Journal of the Japan Primary Care Association
- Vol. 44 (1) , 23-29
Open AccessThe significance of conducting research in primary care, and the two matters essential to produce successful outcomes
筆者はへき地で医師としてのキャリアを始めた.その経験から,日々の臨床現場で湧き上がる疑問や仮説について取り組むPractice based researchを実践し,提唱している.今回,本学会編集委員会より投稿依頼をいただいた.熟慮した結果,プライマリ・ケアで研究をする意義,そしてその研究成果を出すために必要なことについて書くことにした.常日頃から,プライマリ・ケアでの研究について興味を持つ若手は多いものの,なかなか前に進めず経験を積めないということを感じていた.実際にそのような悩みを相談されたこともある.そこでまず,現場での研究をしていくことが楽しくかつ最も良い自己研鑽につながってきたという経験を述べた.次に,そのために大切だと思っている二つのことについて実際の経験を基に書き連ねた.その一つは,キャリアの早期から研究に取り組む意義であり,若手の方々に伝えたいことである.もう一つは,より重要であるが次世代が良い環境で研究を実践するには指導者はどうすれば良いのかである.若手を指導する立場にある,あるいは将来なるであろう中堅の方々に考えていただく,その一助になればと考えている.
- Open Access
- 1 November 2020
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 13, 4353-4359
Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism
Purpose: Sodium-glucose co-transporter-2 (SGLT2) inhibitors have various pleiotropic effects, including body weight reduction, and therefore have the potential to be used in various applications. However, such effects have not been fully investigated; thus, non-clinical studies using animal models are needed. In animal experiments, SGLT2 inhibitors are usually administered by oral or dietary methods. However, the detailed characteristics of these dosing methods, especially to induce their pleiotropic effects, have not been reported. Therefore, we compared the preventive effects of canagliflozin, an SGLT2 inhibitor, on body weight gain following oral gavage and dietary administration methods in a mouse model of diet-induced obesity. Methods: Canagliflozin was dosed by oral gavage or dietary administration for 9 weeks to 6-week-old C57BL/6N mice fed a high-fat diet, and parameters related to obesity were evaluated. Results: The suppression of body weight gain, fat mass, and hepatic lipid content was observed following both dosing methods, whereas the effect on body weight tended to be stronger in the dietary administration group. In adipose tissue, fatty acid synthase expression was significantly decreased in the dietary administration group, and its expression was significantly correlated with fat mass. However, the expression of genes related to fatty acid oxidation was unchanged, indicating that the preventive effect on body weight gain was mediated mainly through the suppression of lipid synthesis rather than the promotion of lipid oxidation. Conclusion: Canagliflozin prevented body weight gain through the suppression of lipid synthesis via both dosing methods, although there were some differences in the efficacy. The findings of our study can help to identify new mechanisms of action of SGLT2 inhibitors and potential applications.
- 1 November 2020
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 13, 4353-4359
Open AccessComparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism
Purpose: Sodium-glucose co-transporter-2 (SGLT2) inhibitors have various pleiotropic effects, including body weight reduction, and therefore have the potential to be used in various applications. However, such effects have not been fully investigated; thus, non-clinical studies using animal models are needed. In animal experiments, SGLT2 inhibitors are usually administered by oral or dietary methods. However, the detailed characteristics of these dosing methods, especially to induce their pleiotropic effects, have not been reported. Therefore, we compared the preventive effects of canagliflozin, an SGLT2 inhibitor, on body weight gain following oral gavage and dietary administration methods in a mouse model of diet-induced obesity. Methods: Canagliflozin was dosed by oral gavage or dietary administration for 9 weeks to 6-week-old C57BL/6N mice fed a high-fat diet, and parameters related to obesity were evaluated. Results: The suppression of body weight gain, fat mass, and hepatic lipid content was observed following both dosing methods, whereas the effect on body weight tended to be stronger in the dietary administration group. In adipose tissue, fatty acid synthase expression was significantly decreased in the dietary administration group, and its expression was significantly correlated with fat mass. However, the expression of genes related to fatty acid oxidation was unchanged, indicating that the preventive effect on body weight gain was mediated mainly through the suppression of lipid synthesis rather than the promotion of lipid oxidation. Conclusion: Canagliflozin prevented body weight gain through the suppression of lipid synthesis via both dosing methods, although there were some differences in the efficacy. The findings of our study can help to identify new mechanisms of action of SGLT2 inhibitors and potential applications.
- Open Access
- 1 May 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (20) , 7033-7045
Glycerol kinase stimulates uncoupling protein 1 expression by regulating fatty acid metabolism in beige adipocytes
- 1 May 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (20) , 7033-7045
Open AccessGlycerol kinase stimulates uncoupling protein 1 expression by regulating fatty acid metabolism in beige adipocytes
- 1 May 2019
- Published by Elsevier in Physiology & Behavior
- Vol. 204, 112-120
Chronic high corticosterone with voluntary corn oil ingestion induces significant body weight gain in mice
- 1 May 2019
- Published by Elsevier in Physiology & Behavior
- Vol. 204, 112-120
Chronic high corticosterone with voluntary corn oil ingestion induces significant body weight gain in mice